STW5 (Iberogast®, BAY98-7411)

DRUG2 trials

Sponsors

Bayer

Conditions

Functional Gastrointestinal Disorders

Phase 2

Study in Patients Suffering From Heartburn and Backward Flow of Stomach Liquid Into the Esophagus

CompletedNCT04059900

BayerFunctional Gastrointestinal Disorders

Start: 2009-06-18End: 2013-05-03Updated: 2019-09-19

Unknown Phase

Study to Learn More About the Onset of Effect of Iberogast in Patients Suffering From Abnormal Stomach and Intestine Function

CompletedNCT04059783

BayerFunctional Gastrointestinal Disorders

Start: 2008-06-17End: 2011-02-20Updated: 2019-09-19